|
|
|
|
|
|
|
CGT Solutions Brochure | Leveraging a partner with expertise and integrated, end-to-end solutions can help overcome obstacles to increase patient access and ensure the safe distribution of your advanced therapy product. | Request Information | Cencora |
|
|
|
UpTempo AAV Platform Process | Catalent’s UpTempo AAV platform process is a scalable, cGMP-ready process for viral vector manufacturing that can reduce the current 18-20-month development timeline for drug product in half. | Request Information | Catalent |
|
|
Cell Therapy Capabilities | Our teams of scientists have 30 years of cell therapy development, manufacturing, and regulatory experience. We support every stage of the product journey, from pre-clinical through commercialization. | Request Information | AGC Biologics |
|
|
Advanced Therapy Solutions | Learn how the right partner can help you overcome regulatory and financial complexities of advanced therapies and ensure product quality and safety through robust logistics support. | Request Information | Cardinal Health |
|
|
Cell Therapy CDMO Services | A trusted partner with the insight and experience to take your cell and gene therapy products from bench to bedside. We know how to accelerate and help you achieve your cell and gene therapy goals. | Request Information | Charles River |
|
|
End-To-End Capabilities | We have the expertise, technologies, and state-of-the-art facilities to deliver cell and gene therapies from concept through commercialization, all under a single roof, right from the start. | Request Information | ElevateBio |
|
|